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Abstract
The vitamin D prophylaxis of rickets in pregnant women and newborns may play a role in early
allergic sensitization. We now asked if an already diseased population may have inherited genetic
variants in the vitamin D turnover or signalling pathway.
Serum levels of calcidiol (25-OH-D3) and calcitriol (1,25-(OH)2-D3) were retrospectively assessed
in 872 partipants of the German Asthma Family Study. 96 DNA single base variants in 13 different
genes were genotyped with MALDI-TOF and a bead array system. At least one positive SNP with
a TDT of p < 0.05 for asthma or total IgE and calcidiol or calcitriol was seen in IL10, GC, IL12B,
CYP2R1, IL4R, and CYP24A1. Consistent strong genotypic association could not be observed.
Haplotype association were found only for CYP24A1, the main calcidiol degrading enzyme, where
a frequent 5-point-haplotype was associated with asthma (p = 0,00063), total IgE (p = 0,0014),
calcidiol (p = 0,0043) and calcitriol (p = 0,0046).
Genetic analysis of biological pathways seem to be a promising approach where this may be a first
entry point into effects of a polygenic inherited vitamin D sensitivity that may affect also other
metabolic, immunological and cancerous diseases.
Background
Asthma is a chronic inflammatory condition of the air-
ways, variable airway obstruction and elevated serum IgE
levels of unclear pathogenesis [1]. A hypothesis relating
early vitamin D supplementation and induction of later
allergy has initially been postulated as the main cholecal-
ciferol metabolite calcitriol may suppresses dendritic cell
maturation and consecutive development of Th1 cells [2]
which is now supported by in vitro, animal and human
studies [3,4].
Exposure studies in humans, however, are difficult as
nearly all newborns in Western countries are now being
exposed in utero or during the first year of life to vitamin
supplements [5,6]. We now asked if there are DNA
sequence variants that are associated with higher or lower
levels of vitamin D metabolites. As it is unlikely that any
complex disease is determined by variants in a single gene
we tested the main genes that code for enzymes in the
metabolic pathway of vitamin D conversion (Figure 1).
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Methods
Study population
The German Asthma Family Study collected affected sib
pairs in 26 paediatric centres in Germany and Sweden for
a two-stage genome-wide linkage scan [7,8]. In these fam-
ilies at least two children were required with confirmed
clinical asthma, while prematurity or low birth weight of
the children were excluded, along with any other severe
pulmonary disease. All affected children over age 3 had a
history of at least 3 years of recurrent wheezing and with
no other airway disease diagnosed. Unaffected siblings
were also sampled if they were at least 6 years old and eli-
gible for pulmonary function testing. Each study partici-
pant signed a consent form. All study methods were
approved by the ethics commission of "Ärztekammer
Nordrhein-Westfalen".
A complete pedigree of the family was drawn and infor-
mation collected in a questionnaire. Participants were
examined for several closely associated phenotypes. Pul-
monary function tests were performed by forced flow vol-
ume tests and bronchial challenge was done by
methacholine (discontinued in the second stage of the
study) as reported earlier [7,8].
The current analysis differs from previous publications
[7,8]. We excluded here all families with at least one mem-
ber of non white skin colour (families 2, 14, 16, 19 to 21
and 27 to 32) as these individuals had considerable lower
levels of 25-OH-D3 (data not shown) compared to all
other participants (Figure 2).
Total IgE was determined with an ELISA (Pharmacia Diag-
nostics, Uppsala, Sweden). 25-OH-D3  was determined
with an enzymatic immunoassay (OCTEIA 25-Hydroxy
Vitamin D kit, Immunodiagnostic Systems IDS, Frankfurt,
Germany) that has a working range of 6–360 nmol/L, an
intra-assay of 8% and inter-assay variation of 10% with a
100% specificity for 25-OH-D3 and 75% specificity for 25-
OH-D2 according to the manufacturer. 1,25-OH2-D3 was
determined by immunoextraction followed by an
enzyme-immunoassay (OCTEIA 1,25-Hydroxy Vitamin D
kit, Immunodiagnostic Systems IDS, Frankfurt, Germany)
that has a working range of 6–500 pmol/L, a 100% specif-
icity for 1,25-OH2-D3 and 0,009% specificity for 25-OH-
D2. 25-OH-D3 values reported are the mean of a duplicate
analysis while due to limited serum availability only sin-
gle assays have been performed for 1,25-OH2-D3.
Control population
191 anonymized DNAs were selected randomly from the
ECRHS II study [9] to fill in remaining slots on the geno-
typing plates. These DNA samples served as population-
based controls to test if the parents of the famillies had
different allele spectrum.
DNA preparation and genotyping
DNA was isolated from peripheral white blood cells using
Qiamp (Qiagen, Germany) or Puregene isolation kits
(Gentra Systems, Minneapolis, MN, USA).
Genes were selected as coding either for key enzymes in
the vitamin D conversion pathway or being regulated by
vitamin D metabolites [10]. SNPs were being picked more
or less randomly either for tagging haplotypes or being
functional relevant [11]. Most SNPs were genotyped using
MALDI-TOF mass spectrometry of allele-specific primer
extension products generated from amplified DNA
Pathway diagram of genes tested for association Figure 1
Pathway diagram of genes tested for association.
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sequences (MassARRAY, SEQUENOM Inc., San Diego,
CA, USA). A few SNPs were also genotyped at Illumina
(San Diego CA, USA) by use of the Sentrix bead arrays.
VDR [12] and IL4R [13] SNP results have been published
earlier and are reanalysed here for the vitamin D levels.
The following SNPs were analyzed (genotyping details
upon request): rs3024498 (IL10), rs3024493 (IL10),
rs1518111 (IL10), rs10000076 (IL10), rs1800872 (IL10),
Il10-571CA (IL10), rs1800895 (IL10), rs1800894 (IL10),
rs1800896 (IL10), rs1800893 (IL10), rs705120 (GC),
rs222040 (GC), rs7041 (GC), rs4752 (GC), rs222011
(GC), rs221999 (GC), rs6811536 (SPP1), rs4754 (SPP1),
rs1042714 (ADRB2), rs1800888 (ADRB2), rs1368439
(IL12B), rs3212227 (IL12B), rs2853697 (IL12B),
rs3213119 (IL12B), rs2853696 (IL12B), rs2853694
(IL12B), rs2288831 (IL12B), rs3213096 (IL12B),
rs2569254 (IL12B), rs3181216 (IL12B), rs3212220
(IL12B), rs3212218 (IL12B), rs1433048 (IL12B),
rs2546890 (IL12B), rs3132299 (RXRA), rs877954
(RXRA), rs1045570 (RXRA), rs10500804 (CYP2R1),
rs1562902 (CYP2R1), rs10766197 (CYP2R1), rs2853563
(VDR), rs731236 (VDR), rs7975232 (VDR), rs1544410
(VDR), rs2239185 (VDR), rs987849 (VDR), rs1540339
(VDR), rs3819545 (VDR), rs3782905 (VDR), rs2239186
Median, quartile and outlier of 25-OH-D3 serum levels in 872 participants of the German Asthma Family Study with white skin  colour by month of examination Figure 2
Median, quartile and outlier of 25-OH-D3 serum levels in 872 participants of the German Asthma Family Study with white skin 
colour by month of examination.
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(VDR), rs2228570 (VDR), rs1989969 (VDR), rs2853564
(VDR), hCV2880804 (VDR), rs238532 (CYP27B1),
rs2072052 (CYP27B1), rs1048691 (CYP27B1),
rs4646537 (CYP27B1), rs4646536 (CYP27B1),
rs8176345 (CYP24A1), rs703842 (CYP27B1), I50V
(IL4R), rs2234897 (IL4R), rs1805011 (IL4R), C406R
(IL4R), rs1805015 (IL4R), Q551R (IL4R), rs1805016
(IL4R), rs10000306 (CARD15), rs2076753 (CARD15),
rs2066842 (CARD15), rs2066843 (CARD15), rs2076756
(CARD15), rs10000331 (CARD15), rs3135499
(CARD15), rs3135500 (CARD15), rs375947 (IL12RB1),
rs447009 (IL12RB1), rs436857 (IL12RB1), rs2045387
(IL12RB1), rs8118441 (CYP24A1), rs751089 (CYP24A1),
rs6068816 (CYP24A1), rs4809958 (CYP24A1),
rs2244719 (CYP24A1), rs2296241 (CYP24A1),
rs17219266 (CYP24A1), rs6022999 (CYP24A1),
rs17219315 (CYP24A1), rs11699278 (CYP24A1),
rs2762942 (CYP24A1), rs2248137 (CYP24A1),
rs2762943 (CYP24A1), rs2585427 (CYP24A1),
rs2248359 (CYP24A1) and rs2426496 (CYP24A1).
Data handling and statistical analysis
Clinical data and genotypes were all transferred to a SQL
2000 database and checked for completeness, paternity,
and Hardy-Weinberg equilibrium. Further analyses were
performed using R 2.0 statistical software[14]. Linkage
disequilibrium was determined by Haploview [15] using
the Gabriel method for block definition. TDT association
for quantitative and qualitative traits was done with SIB-
PAIR [16] using the TDT option for qualitative and the
Haseman-Elston regression for quantitative traits. Family-
based haplotype association analysis was performed by
FBAT [17] using a dominant model.
Bioinformatics
SNP information was obtained from dbSNP [18], Innate
Immunity PGA [19] and UCSC genome browser [20].
SNP selection was done with the help of Perlegen [21] and
Hapmap [22] data. Sequence context annotation was
done by SNPper [23], PUPA [24], TAMAL [25] and SNPPi
[26]).
Results
The total sample consisted of 947 individuals from 224
families where 872 serum measurements of 25-OH-D3,
876 1,25- OH2-D3 and 934 total IgE measurements could
be performed. After exclusion of non-white families 903
individuals from 201 families remained under analysis
with 812 assays of 25-OH-D3, 807 1,25- OH2-D3 and 903
total IgE.
Clinical details of the families are given in table 1. Mean
25-OH-D3 level in children was 68 nmol/l (s.d. 38 nmol/
l). 50% of values fell below and 17% above the Merck
manual reference range of 62.4 to 99.8 nmol/l. Mean
1,25- OH2-D3 in children was 102 pmol/l (s.d. 38 nmol/
l). 3% of values fell below and 40% above the Merck man-
ual reference range of 48.4 to 108 pmol/l. The highest
measured value was 257 pmol/l in two children from
unrelated families.
There were no major differences in serum levels between
children and parents. There was also no major influence
by sex or age. An important factor, however, was found
with month of examination representing seasonal sun
exposure in mid Europe (Figure 2). Even after serum stor-
age of 10 years, the individual 25-OH-D3 levels followed
a clear time course with a major peak in August. The hor-
monal form 1,25-OH2-D3 did not vary over the course of
the year, as the conversion rate decreased with higher lev-
els of 25-OH-D3 (Figure 3).
The overall heritability index H2 for 25-OH-D3 was 80.3%
while the H2 for 1,25-OH2-D3 was only 30.0% [27]. There
was neither an association of 25-OH-D3 and total IgE nor
an association of 1,25-OH2-D3 and total IgE levels.
13 genes were selected for genotyping (IL10, GC, SPP,
ADRB2, IL12B, RXRA, CYP2R1, VDR, CYP27B1, IL4R,
CARD15, IL12RB1, CYP24A1) and could be successfully
completed for 96 SNPs. 4 of these SNPs were not in
Hardy-Weinberg equilibrium: rs221999 (GC, P =
0,0299), rs10500804 (CYP2R1, P = 0,0498), rs10766197
(CYP2R1, P = 0,0100) and rs2248359 (CYP24A1, P =
0,0299). SNP rs221999 was also not in Hardy-Weinberg
equilibrium in controls. The population-based controls
showed similar allele frequencies compared to the family
samples except for SNPs rs4754, rs2288831 and
rs3819545.
Table 1: Clinical characteristics of the included 210 families of 
the German Asthma Family
Parents Children
n/N or mean/s.d. n/N or mean/s.d.
age/years) 43.2/6.1 13.6/4.6
female sex 204/408 (50.0%) 207/474 (43.7%)
height(cm) 172.3/9.6 149.0/19.6
weight(kg) 76.4/15.1 42.8/17.2
asthma diagnosis 99/408(24.3%) 416/474 (87.8%)
Eczema 51/382(13.4%) 184/448 (41.1%)
allergic rhinitis 163/406 (40.1%) 280/474 (59.1%)
D.pter. (D1) > 0.5 kU/l 109/340 (32.1%) 243/422 (57.6%)
D.far. (D2) > 0.5 kU/l 103/341 (30.2%) 236/422 (55.9%)
grass(GX1) > 0.5 kU/l 129/340 (37.9%) 293/422 (69.4%)
birch (T3) > 0.5 kU/l 122/339 (36.0%) 213/423 (50.4%)
mean positive RASTs 2.6/2.9 4.8/3.5
Eosinophils 103/µl 0.2/0.2 0.4/0.4
IGE kU/l 185.0/371.8 480.6/701.3
mean RAST > 0.5 kU/l 2.6/2.9 4.8/3.5Respiratory Research 2006, 7:60 http://respiratory-research.com/content/7/1/60
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SNP allele transmission in 7 of the tested 13 genes showed
a p-value of less than 0.05 when testing for 25-OH-D3 lev-
els (IL10, GC, ADRB2, CYP2R1, IL4R, IL12RB1 and
CYP24A1, see table 2) while only 3 showed transmission
disequilibrium with 1,25-OH2-D3 (IL10, IL12B and
CYP24A1). SNPs in 5 genes showed a p-value < 0.05 with
asthma (IL10, IL12B, VDR, CARD15 and CYP24A1). Most
significances, however, were weak. For 96 SNPs we would
expect 4.8 tests to be positive for each trait which was
exceeded by testing asthma (N = 8), total IgE (N = 13), 25-
OH-D3 (N = 8) but not 1,25-OH2-D3(N = 3). Only 2 SNP
showed an effect with both traits, one in CYP2R1
(rs10766197) and one in IL4R (rs1805011). rs10766197
is situated in the CYP2R1 promotor; while rs1805011 is
leading to an Ala- > Glu amino acid exchange in the IL4
receptor.
D-ratio (log(1,25-OH2-D3) [pmol/l]/log(25-OH-D3) [nmol/l]) versus 25-OH-D3 in in 867 participants of the German Asthma  Family Study with white skin colour Figure 3
D-ratio (log(1,25-OH2-D3) [pmol/l]/log(25-OH-D3) [nmol/l]) versus 25-OH-D3 in in 867 participants of the German Asthma 
Family Study with white skin colour.
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In a next step we performed multivariate regression in the
parental dataset while adjusting for age, sex, and month of
examination (table 3). This confirmed 11 SNPs already
found in the family based-aproach; again, association
results were weak. Some CARD15 variants had an asthma
protective effect while IL12B SNPs carried risk alleles.
Haplotypes were constructed from all significantly associ-
ated SNPs (table2). No significant association was found
in any of the 13 genes except for CYP24A1 where a 5-point
frequent haplotype
(rs2296241:rs17219315:rs2762942:rs2248137:rs224835
9) spanning both LD blocks of CYP24A1 was associated
with a diagnosis of asthma (p = 0.001), total IgE (p =
0.001), 25-OH2-D3 (p = 0.004) and 1,25-OH2-D3 serum
level (p = 0.005, table 4).
Discussion
We have shown that serum 25-OH-D3 (calcidiol) levels -
although highly influenced by environmental sunlight
exposure- is a heritable trait in asthma families. In con-
trast, a major genetic influence on 1,25-OH2-D3 (calci-
triol) levels could not be found, a finding that requires
replication in further family and population-based stud-
ies.
The reason for this discrepancy is not fully clear as the
conversion of 25-OH-D3 to 1,25-OH2-D3 is closely regu-
lated by a direct feedback loop. It is generally agreed, how-
ever, that 25-OH-D3 reflects best the current vitamin D
status [28]. Unfortunately standardized reference values
for this age group are not available but values for 25-OH-
D3 in children seem to be in the upper normal range [29].
An explanation therefore could be that a delayed down-
stream metabolism is leading to an (unintended) afflux or
-also possible- that an increased peripheral demand needs
a larger reservoir.
We observed a number of positive associations with single
nucleotide polymorphisms. Although the selection of
Table 2: Transmission approach: TDT results of 30 from 96 tested SNPs in 210 families of the German Asthma Family Study. Shown 
are only SNPs with at least one TDT results of p < 0.05. The underlined 11 SNPs also appear in table 3.
SNP Gene Genomic 
position HG17
MAF P asthma P log(IgE) P log(25- OH-
D3)
P log(1,25- 
OH2-D3)
rs3024498 IL10 1203329924 0,26 0,2654 0,4625 0,0093 0,4479
rs1518111 IL10 1203333040 0,22 0,7087 0,0487 0,4962 0,6031
rs10000076 IL10 1203334410 0,02 0,3711 0,2364 0,2374 0,0030
Il10-571CA IL10 1203334805 0,24 0,0247 0,3310 0,5889 0,3857
rs1800895 IL10 1203334867 0,01 0,0039 0,5237 0,1152 0,3891
rs1800894 IL10 1203335061 0,03 0,7773 0,5154 0,0101 0,1727
rs222040 GC 4072981967 0,43 0,9211 0,0163 0,3829 0,0662
rs7041 GC 4072983369 0,43 0,8812 0,0249 0,3884 0,0827
rs221999 GC 4073014083 0,24 0,1475 0,2755 0,0027 0,1920
rs1042714 ADRB2 5148186666 0,40 0,8532 0,8492 0,0139 0,7524
rs1433048 IL12B 5158688423 0,18 0,3452 0,5814 0,4184 0,0339
rs2546890 IL12B 5158692478 0,45 0,0236 0,9066 0,5667 0,1599
rs10500804 CYP2R1 11014866849 0,45 0,2242 0,0418 0,0833 0,8352
rs1562902 CYP2R1 11014874792 0,43 0,1342 0,0443 0,1063 0,8049
rs10766197 CYP2R1 11014878456 0,48 0,4700 0,0284 0,0459 0,7258
rs7975232 VDR 12046525104 0,49 0,2484 0,0400 0,9235 0,9351
rs2239186 VDR 12046555677 0,19 0,0350 0,7521 0,9212 0,5459
rs1805011 IL4R 16027281373 0,11 0,2334 0,0090 0,1110 0,2684
C406R IL4R 16027281467 0,15 1,0000 0,0255 0,6542 0,1249
rs1805015 IL4R 16027281681 0,16 0,8744 0,0003 0,4956 0,1197
Q551R IL4R 16027281901 0,25 0,2482 0,0017 0,9661 0,8287
rs1805016 IL4R 16027282428 0,05 0,2076 0,0082 0,0002 0,7390
rs10000306 CARD15 16049288266 0,04 0,6473 0,0417 0,4739 0,5429
rs3135499 CARD15 16049323628 0,37 0,0374 0,2742 0,3929 0,8405
rs2045387 IL12RB1 19018061586 0,24 0,6826 0,7907 0,0145 0,3191
rs2296241 CYP24A1 20052219626 0,50 0,0046 0,9291 0,8917 0,5098
rs17219315 CYP24A1 20052221853 0,02 0,8658 0,6289 0,0095 0,3056
rs2762942 CYP24A1 20052222332 0,04 0,7140 0,1506 0,2030 0,0397
rs2248137 CYP24A1 20052223150 0,39 0,0256 0,8250 0,2567 0,9096
rs2248359 CYP24A1 20052224925 0,36 0,0158 0,9302 0,2284 0,8510R
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Table 3: Case-control approach: Multivariate regression results of 31 from 96 tested SNPs in 408 parents of the German Asthma Family Study adjusted for age, sex and month 
of examination. Shown are only SNPs with at least one p < 0.05 for heterocygotes and homocygote carriers of the minor allele. The underlined 11 SNPs also appear in table 2.
SNP Gene P asthma P log(IgE) P log(25-OH- D3) P log(1,25-OH2-D3)
heterocygote homocygote heterocygote homocygote heterocygote homocygote heterocygote homocygote
ß coeff. P ß coeff. P ß coeff. P ß coeff. P ß coeff. P ß coeff. P ß coeff. P ß coeff. P
rs3024498 IL10 0,132 0,837 -0,140 0,822 0,875 0,034 1,026 0,011 0,002 0,984 0,068 0,575 -0,022 0,819 0,014 0,883
Il10571CA IL10 1,731 0,024 1,225 0,080 0,446 0,362 0,241 0,608 0,171 0,290 0,252 0,110 -0,080 0,484 -0,090 0,421
rs6811536 SPP1 0,215 0,632 0,266 0,555 0,532 0,069 0,687 0,019 0,159 0,112 0,149 0,136 -0,048 0,528 -0,038 0,623
rs3213119 IL12B -13,300 0,988 -13,765 0,988 2,221 0,149 2,950 0,050 -0,125 0,799 -0,124 0,795 -0,063 0,869 -0,090 0,808
rs2853694 IL12B -0,295 0,394 -0,845 0,020 0,212 0,288 0,272 0,216 -0,076 0,241 -0,092 0,200 0,069 0,173 0,003 0,952
rs3181216 IL12B 0,729 0,058 0,972 0,013 -0,306 0,231 -0,300 0,238 0,086 0,322 0,191 0,029 0,090 0,180 0,051 0,446
rs1433048 IL12B 0,632 0,412 0,595 0,427 0,916 0,077 1,074 0,034 0,082 0,658 0,019 0,916 0,063 0,656 0,037 0,792
rs2546890 IL12B -0,367 0,293 -0,808 0,026 0,166 0,391 0,272 0,199 -0,059 0,355 -0,074 0,291 0,002 0,969 -0,033 0,547
rs3132299 RXRA -15,303 0,986 -15,118 0,987 0,803 0,181 0,383 0,517 0,032 0,873 0,108 0,587 0,319 0,042 0,366 0,018
rs877954 RXRA -0,433 0,301 -0,258 0,551 0,345 0,163 -0,119 0,640 0,175 0,029 0,156 0,059 0,031 0,616 -0,003 0,965
rs10500804 CYP2R1 0,279 0,394 0,287 0,434 0,212 0,323 0,421 0,077 0,069 0,323 0,191 0,014 0,032 0,554 -0,001 0,982
rs1562902 CYP2R1 -0,071 0,846 0,020 0,960 -0,020 0,930 0,026 0,917 -0,108 0,143 -0,202 0,011 0,038 0,517 0,050 0,426
rs10766197 CYP2R1 -0,112 0,733 0,014 0,970 0,259 0,202 0,377 0,104 0,074 0,266 0,181 0,017 0,032 0,532 -0,018 0,757
rs1544410 VDR -0,105 0,786 -0,268 0,496 -0,350 0,145 -0,149 0,544 0,041 0,592 0,111 0,165 -0,120 0,040 0,047 0,441
rs2239185 VDR 0,620 0,041 0,554 0,110 -0,184 0,352 -0,187 0,408 -0,022 0,730 -0,007 0,920 -0,110 0,028 -0,034 0,544
rs2239186 VDR -0,274 0,669 0,289 0,641 0,638 0,121 0,558 0,160 -0,268 0,040 -0,163 0,193 -0,218 0,036 -0,156 0,119
rs2228570 VDR 0,708 0,104 0,834 0,058 0,481 0,108 0,653 0,029 -0,100 0,279 -0,073 0,435 -0,042 0,537 -0,001 0,988
rs238532 CYP27B1 -0,449 0,577 0,626 0,214 0,647 0,144 -0,075 0,813 -0,025 0,857 0,081 0,463 0,281 0,009 -0,063 0,456
rs703842 CYP27B1 -0,467 0,316 -0,391 0,401 0,549 0,036 0,525 0,045 -0,041 0,631 0,046 0,589 -0,064 0,335 -0,022 0,738
rs1805011 IL4R -13,530 0,986 -13,774 0,986 -2,094 0,024 -1,752 0,053 0,559 0,049 0,497 0,073 0,193 0,382 0,212 0,329
rs2076753 CARD15 -1,152 0,044 -1,300 0,023 0,093 0,738 0,137 0,625 0,062 0,483 0,057 0,526 0,000 0,998 -0,059 0,397
rs2066842 CARD15 -1,260 0,028 -1,416 0,013 -0,039 0,884 0,083 0,757 0,037 0,669 0,014 0,871 0,028 0,673 -0,038 0,560
rs2066843 CARD15 -1,221 0,033 -1,301 0,023 -0,066 0,813 0,055 0,842 0,007 0,939 0,010 0,912 0,016 0,819 -0,041 0,544
rs2076756 CARD15 -1,396 0,031 -1,427 0,027 -0,142 0,627 0,073 0,800 0,077 0,410 0,055 0,552 0,035 0,627 -0,029 0,680
rs375947 IL12RB1 1,012 0,011 0,580 0,125 0,117 0,653 0,087 0,733 0,133 0,116 0,063 0,443 0,140 0,027 -0,011 0,858
rs2244719 CYP24A1 0,257 0,407 -0,029 0,931 -0,045 0,817 0,184 0,389 0,139 0,029 0,025 0,723 0,165 0,001 0,114 0,031
rs2296241 CYP24A1 0,042 0,889 0,548 0,125 0,101 0,609 -0,018 0,934 0,160 0,012 0,030 0,669 -0,058 0,236 0,039 0,463
rs2248137 CYP24A1 -0,104 0,776 -0,253 0,503 0,320 0,145 0,117 0,609 0,038 0,599 -0,024 0,748 -0,120 0,028 -0,131 0,021
rs2762943 CYP24A1 15,934 0,986 15,861 0,986 -3,140 0,041 -3,193 0,036 -0,146 0,763 -0,195 0,684 -0,878 0,018 -0,784 0,033
rs2248359 CYP24A1 -0,109 0,793 -0,460 0,245 0,230 0,345 0,057 0,805 -0,023 0,766 -0,019 0,803 -0,137 0,025 -0,112 0,056
rs2426496 CYP24A1 0,415 0,403 -0,091 0,848 -0,045 0,886 -0,225 0,464 0,207 0,038 0,165 0,091 -0,060 0,436 -0,076 0,314Respiratory Research 2006, 7:60 http://respiratory-research.com/content/7/1/60
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candidate genes was rather subjective, it turned out that
some of the tested candidate genes are associated with
both allergy and vitamin D metabolites. Statistical signif-
icance, however, was weak, and varied even with different
analysis strategies and software packages (unpublished
own observation). There was also no fully consistent pat-
tern when comparing the family transmission and the
case-control approach which makes it unlikely that any of
the tested SNPs is already an important functional variant.
The new associations may instead indicate the effects of
physically closely related variants in these genes (which is
also supported by the haplotype results of CYP24A1).
The associated candidate genes are of particular interest.
CYP24A1 is the major enzyme of the calcitriol degrada-
tion pathway that showed nearly 100-fold increase after
vitamin D treatment of rats [30]. Previous studies also
suggest that CYP24A1 null mice cannot clear calcitriol
efficiently [31] which would support the above men-
tioned afflux hypothesis. An alternative splicing variant in
CYP24A1 has been described recently [32] leading to a
truncated and catalytically dysfunctional protein while it
is unclear if any of our tested SNPs will have functional
relationship to this protein variant. Dark skinned Asian
Indians seem to have increased 24-hydroxylase activity
compared to white skinned Caucasians [33] whereas both
skin colour and metabolic capacity seem to be adapted to
less sun light exposure in Caucasians.
The evidence that the human CYP2R1 is a key vitamin D
25-hydoxylase is rather new [34] where the identity of the
hepatic 25-hydroxylase has remained unclear for several
decades. At least six CYPs can catalyze this step where the
most viable candidates are CYP27A1 and CYP2R1 [34]
Genomic organization of CYP24A1 gene, location of genotyped SNPs, linkage disequilibrium between SNPs (with R2 indicated  by bullet size) and LD block structure (highlighted by red boxes; rs2248359 was excluded from LD calculations for not being in  HWE) Figure 4
Genomic organization of CYP24A1 gene, location of genotyped SNPs, linkage disequilibrium between SNPs (with R2 indicated 
by bullet size) and LD block structure (highlighted by red boxes; rs2248359 was excluded from LD calculations for not being in 
HWE). SNPs indicated by ¶ were used to build haplotypes.Respiratory Research 2006, 7:60 http://respiratory-research.com/content/7/1/60
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with the renal enzyme responsible for 1-α-hydroxylation
being CYP27B1. A loss of function mutation in CYP2R1
has also been described [34] and deserves further testing.
Variants in CYP2R1, CYP27B1 and CYP24A1 or other
genes in the metabolic pathway of vitamin D have not
been tested so far with asthma or allergy but several of the
VDR-controlled genes tested here already have been asso-
ciated with asthma and allergy. These include IL12B [35-
37], IL12RB [38,39], IL10 [40], VDR [41,42,12], GC [43],
ADRB2 [44], CARD15 [45] and IL4R [46].
Of these, IL12B is a particular interesting cytokines. Mac-
rophage engulfed microorganism are leading to IL12p70
production, a heterodimer of IL12p40 (IL12B) and
IL12p35 (IL12A), which is a primary inducer of Th1 cell
development and a critical factor in the development of
allergy [47]. Also IL10 seems to be important where pro-
duction in circulating T cells from atopic asthmatics is
maximally stimulated [48]; allergen specific IL10 produc-
ing T regulatory cells can inhibit allergen specific effector
cells and represent an important line of defense in the
allergic reaction [49]. Functional variants in these genes
leading to human disease are not known so far.
The many positive but weak associations represent a com-
mon dilemma in complex disease. In asthma more than
75 genes have now been claimed to be associated [50] but
none of them has been shown to contribute to risk in all
populations studied [51]. Obviously there are only small
genetic effects and a large heterogeneity; sometimes there
is unidentified population stratification and there might
be phenotyping and genotyping errors. Most likely, how-
ever, not the "center" SNPs have been choosen [11]. The
current pathway based approach seems to be an alterna-
tive in particular when an environmental trait can be
included. It is likely that some of the genes identified here
are acting in concert to determine the overall vitamin D
sensitivity.
Besides increasing sample size and testing additional pop-
ulations, further work may concentrate on monitoring
vitamin D supplementation by immunological readouts
and the identification of contributing functional genetic
elements. The present rediscovery of a genetic vitamin D
sensitivity [52] may be an important step in allergy induc-
tion and also surmount many other diseases including
type 1 diabetes, osteoporosis, tuberculosis, rheumatoid
arthritis, multiple sclerosis, inflammatory bowel diseases,
and prostate cancer where adequate vitamin D support
has been found to be beneficial.
Abbreviations
SNP = single nucleotide polymorphism
D3 = cholecalciferol, vitamin D
25-OH-D3 = calcidiol
1,25-OH2-D3 = calcitriol
CYP24A1 = cytochrome P450, family 24, subfamily A,
polypeptide 1
VDR = nuclear vitamin D receptor
IL12B = interleukin 12 B (cytotoxic lymphocyte matura-
tion factor 2, p40)
Table 4: CYP24A1 haplotype transmission results in 213 families of the German Asthma Family Study. Haplotype was formed from all 
SNPs with p < 0.05 in the TDT (table 2).
h1 h2 h3 h4 h5 h6 h7
SNP rs2296241 G A A G G A A
r s 1 7 2 1 9 3 1 5 AAAAAAG
r s 2 7 6 2 9 4 2 AAAGAAA
rs2248137 C G C C G G G
rs2248359 C T C C T C T
frequency 0,40 0,31 0,15 0,04 0,03 0,03 0,02
asthma Z value 3,42 -2,11 -1,43 0,10 NA NA NA
P value 0,001 0,035 0,153 0,919 NA NA NA
log(IgE) Z value 3,19 -1,97 -1,26 -0,46 0,71 NA -0,79
p value 0,001 0,049 0,208 0,645 0,478 NA 0,432
log(25-OH-
D3)
Z value 2,85 -2,25 -1,03 0,08 1,59 NA -0,22
P value 0,004 0,025 0,305 0,935 0,112 NA 0,823
log(1,25-
OH2-D3)
Z value 2,83 -1,94 -1,38 0,10 1,50 NA -0,09
p value 0,005 0,052 0,167 0,922 0,134 NA 0,932Respiratory Research 2006, 7:60 http://respiratory-research.com/content/7/1/60
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RXRA = retinoid X receptor α
IL4R = interleukin 4 receptor
ADRB2 = ß2 adrenergic receptor
IL12RB1 = interleukin 12 receptor, ß1
IL10 = interleukin 10
GC = group-specific component (vitamin D binding pro-
tein)
CYP2R1 = cytochrome P450, family 2, subfamily R,
polypeptide 1
CARD15 = caspase recruitment domain family, member
15 (NOD2)
SPP1 = secreted phosphoprotein 1, osteopontin (OPN,
ETA-1, BNSP,...)
CYP27B1 = cytochrome P450, family 27, subfamily B,
polypeptide 1
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